VV
Viraj Vilas Nevrekar
About Viraj Vilas Nevrekar
Data last updated:
Viraj Vilas Nevrekar is a Designated Partner at Sky Oncology Llp (since 2024) and Director at Ictc Foundation (since 2024). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹18.07 Cr; the largest is Sky Oncology Llp at ₹18.06 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 03 Apr 2024 | 2023 | ₹18.06 Cr (FY 2025) | Active | |
| Director | 10 Jan 2024 | 2024 | ₹20,000 (FY 2025) | Active |
Board colleagues of Viraj Vilas Nevrekar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Yeshwant Ghanekar | 10167039 | Sky Oncology Llp , Ictc Foundation | Designated Partner |
| Rohit Ramesh Pai | 10266251 | Sky Oncology Llp , Ictc Foundation | Designated Partner |
| Salil Vijay Patkar | 09040557 | Sky Oncology Llp , Ictc Foundation | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Viraj Vilas Nevrekar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viraj Vilas Nevrekar
Viraj Vilas Nevrekar currently holds 2 directorships: Sky Oncology Llp (Designated Partner, since 03 Apr 2024, revenue ₹18.06 Cr (FY 2025)); Ictc Foundation (Director, since 10 Jan 2024, revenue ₹20,000 (FY 2025)).
Viraj Vilas Nevrekar was first appointed on 10 Jan 2024 as Director at Ictc Foundation.
The 2 current companies of Viraj Vilas Nevrekar that report revenue have a combined latest revenue of ₹18.07 Cr: Sky Oncology Llp ₹18.06 Cr (FY 2025); Ictc Foundation ₹20,000 (FY 2025).
The current boards of Viraj Vilas Nevrekar's companies include Amit Yeshwant Ghanekar (Sky Oncology Llp), Rohit Ramesh Pai (Sky Oncology Llp), Salil Vijay Patkar (Sky Oncology Llp).